行動醫療（行動健康）與在宅觀測：第4版 是由出版商Berg Insight AB在2011年12月所出版的。
這份英文市場調查報告書價格從美金1500起跳。
電子健康醫療這個名詞的意思是透過電子性程序以及通信的醫療活動。而在最近，透過攜帶電話以及手機網路的電子健康醫療的m health（行動健康醫療）這個詞會出現了。行動健康醫療包含原則性的各種類行動醫療相關通信、應用或者資料數據服務的相關而非常廣泛的表現。嵌入了通信功能的在宅監測系統的數量，從2010年到2016年的CAGR（複合年度成長率）預估為18.0%、全球的接續數在2016年末預計課達到490萬、Berg Insight如此預測著。
本報告書為全球行動健康醫療以及在宅監測市場的動向與前景相關的調査分析、主要行動裝置業者的行動健康醫療戰略、主要技術、以及在宅醫療監測的動向ˋ 之整理、主要的生理學、藥物治療、以及統合監測對策供應商的紹介，同時包含2016年為止的市場預測之提示等，概述如下。
總綱
第1章 生活習慣病的課題
第2章 行動裝置業者的行動健康醫療戰略
- 行動健康醫療服務之通信
- 行動健康醫療市場分類
- 商務模式
- 北美的行動裝置業者行動健康醫療戰略
- 歐洲的行動裝置業者的行動健康醫療戰略
- 亞太地區的行動裝置業者行動健康醫療戰略
第3章 實現技術以及趨勢
- 無線M2M（機器對機器）技術
- 行動裝置端末
- 個人健康記録趨勢
- 業界團體
第4章 在宅醫療監測
第5章 生理學的監測對策供應商
- 心臟監測
- 血壓監測
- 凝血監測
- 睡眠監測
- 血氧監測
- 空氣循環監測
- 血糖値監測
- 脂質監測
第6章 藥物治療以及整合監測對策供應商
第7章 市場分析與預測
- 市場分析
- 市場預測
- 市場成長促進以及阻礙要因
- 潛在的市場觸媒
- 對行動裝置業界相關企業的提案
用語集
Abstract
Executive summary
eHealth is a term for healthcare practice supported by electronic processes
and communication. More recently, mHealth has begun to appear as a term for
eHealth using mobile phones or cellular networks. mHealth is a very broad term
that principally involves every kind of mobile health related communication,
application or data service. This report covers home health monitoring
involving patient self-testing using medical devices and remote transmission
of the medical data to healthcare providers for disease management. Some of
the most common conditions being monitored today are chronic diseases
including cardiac arrhythmia, hypertension, ischemic diseases, sleep apnea,
diabetes, hyperlipidemia, asthma and chronic obstructive pulmonary disease
(COPD). These conditions cause substantial costs and reduce both life
expectancy and quality of life. Berg Insight estimates that more than 200
million people in the EU and the US suffer from one or several diseases where
home monitoring can become a treatment option. Applying information and
communication technologies in the healthcare industry can lead to decreased
costs, more efficient care delivery and improved sustainability of the
healthcare system. However, the rate of adoption is still slow and wireless
technologies have only just begun to penetrate the market.
At the end of 2011, around 2.2 million patients worldwide were using a home
monitoring service based on equipment with integrated connectivity. The figure
does not include patients that use monitoring devices connected to a PC or
mobile phone. It only includes systems that rely on monitors with integrated
connectivity or systems that use monitoring hubs with integrated cellular or
fixed-line modems. Berg Insight forecasts that the number of home monitoring
systems with integrated communication capabilities will grow at a compound
annual growth rate (CAGR) of 18.0 percent between 2010 and 2016 to reach 4.9
million connections globally by the end of the forecast period. The number of
these devices that have integrated cellular connectivity increased from 0.42
million in 2010 to about 0.57 million in 2011, and is projected to grow at a
CAGR of 34.6 percent to 2.47 million in 2016.
Several companies have developed integrated solutions for monitoring multiple
chronic diseases and other conditions. The six leading providers of integrated
telehealth systems include the major technology and electronics companies
Bosch, Honeywell, Philips and Bayer, as well as the small specialist
telehealth companies Cardiocom and Numera. Combined, these six companies
account for 73.0 percent of the installed base of telehealth hubs. The main
market segments for medical devices with integrated connectivity are cardiac
rhythm management, sleep therapy and cardiac event monitoring. In these
segments leading providers such as Medtronic, Biotronik, St. Jude Medical,
CardioNet, LifeWatch, ResMed, Philips Respironics and Fisher & Paykel
Healthcare today market wirelessly connected solutions. Implantable cardiac
rhythm management devices is by far the largest segment, accounting for 74.3
percent of remotely monitored patients.
The major mobile operator groups including AT&T, Orange, Telefonica and
Vodafone are currently exploring the field and have set up business units
dedicated to mHealth. The most commonly used mode of expansion has been to
establish strategic partnerships with mHealth and eHealth solution vendors.
Several operators are leveraging other vehicles for expansion such as
corporate venture capital, acquisitions and in-house development. However,
providing specialized solutions for the healthcare industry implies a
significant diversification from the core business. The challenge for mobile
operators is to identify market segments where they create most value, while
at the same time limiting the potential downsides of over-diversification.
The adoption of out-of-hospital wireless monitoring in healthcare is driven by
a wide range of incentives, related to everything from demographics and
technology development to new advancements in medical treatment. However,
there are a number of barriers, including resistance to change among
healthcare organizations and clinicians, misaligned incentive structures and
the financing of wireless solutions by what is at large an underfunded
healthcare sector. Several catalysts are nevertheless likely to speed up the
rate of adoption, including increasing monitoring during clinical trials,
insurance company requirements and new clinical evidence on cost
effectiveness. Significant events that will drive uptake include the Medical
Device Data Systems (MDDS) legislation in the US and the publication of the
results from the Whole System Demonstrator project in the UK.
Table of Contents
Table of Contents
List of Figures
Executive summary
1. The challenge from welfare diseases
- 1.1. Introduction
- 1.1.1. The ageing world population
- 1.1.2. Metabolic syndrome and lifestyle related diseases
- 1.2 Common chronic diseases
- 1.2.1. Cardiac arrhythmia
- 1.2.2. Hypertension
- 1.2.3. Ischemic diseases
- 1.2.4. Sleep apnea
- 1.2.5. Chronic respiratory diseases
- 1.2.6. Diabetes
- 1.2.7. Hyperlipidemia
- 1.3. Healthcare providers and reimbursement systems
- 1.3.1. Healthcare in Asia-Pacific
- 1.3.2. Healthcare in Europe
- 1.3.3. Healthcare in North America
2. mHealth strategies of mobile operators
- 2.1. Telecommunications in mHealth services
- 2.2. mHealth market segments
- 2.3. Business models
- 2.4. mHealth strategies of mobile operators in North America
- 2.4.1. Verizon Communications
- 2.4.2. AT&T
- 2.4.3. Sprint
- 2.4.4. KORE Telematics
- 2.4.5. GreatCall
- 2.4.6. TELUS
- 2.4.7. SaskTel
- 2.5. mHealth strategies of mobile operators in Europe
- 2.5.1. Vodafone
- 2.5.2. Deutsche Telecom
- 2.5.3. Orange Group
- 2.5.4. Telefonica
- 2.5.5. KPN
- 2.5.6. Telecom Italia
- 2.6. mHealth strategies of mobile operators in Asia-Pacific
- 2.6.1. NTT DoCoMo
- 2.6.2. SK Telecom
- 2.6.3. Telstra
3. Enabling technologies and initiatives
- 3.1. Wireless M2M technology
- 3.1.1. Chipsets, modules and terminals
- 3.1.2. Device design and machine integration
- 3.1.3. M2M device value chain
- 3.1.4. eDevice focuses on end-to-end M2M solutions for telehealth
- 3.1.5. Qualcomm launches the 2net Platform and Hub
- 3.1.6. Wireless M2M module vendors in the mHealth market
- 3.2. Mobile handsets
- 3.2.1. Smartphone vendors and operating systems
- 3.2.2. Application stores provide a new channel to the market for
developers
- 3.2.3. Medical applications
- 3.3. Personal health record initiatives
- 3.3.1. Google shuts down Google Health
- 3.3.2. Microsoft HealthVault
- 3.3.3. Dossia personal health platform
- 3.3.4. PatientsLikeMe
- 3.4. Industry associations
- 3.4.1. Continua Health Alliance
- 3.4.2. The Bluetooth SIG Medical Working Group
- 3.4.3. American Telemedicine Association
- 3.4.4. CTIA
- 3.4.5. GSMA
- 3.4.6. mHealth Alliance
- 3.4.7. West Wireless Health Institute
- 3.4.8. Wireless-Life Sciences Alliance
4. Home healthcare monitoring
- 4.1. Trends in health monitoring
- 4.1.1. Going digital, going wireless
- 4.1.2. Distance disease management
- 4.1.3. Outsourcing of health monitoring
- 4.2. Medical monitoring devices
- 4.2.1. Cardiac monitoring
- 4.2.2. Blood pressure monitoring
- 4.2.3. Blood coagulation monitoring
- 4.2.4. Blood oxygen level monitoring
- 4.2.5. Glucose monitoring
- 4.2.6. Lipid monitoring
- 4.2.7. Sleep monitoring
- 4.2.8. Breath monitoring
- 4.3. Regulatory environment
- 4.3.1. Regulatory environment in Europe
- 4.3.2. Regulatory environment in the US
- 4.3.3. Regulatory environment on other major markets
- 4.3.4. International standardisation
5. Physiological monitoring solution providers
- 5.1. Cardiac monitoring
- 5.1.1. Biotronik
- 5.1.2. Boston Scientific
- 5.1.3. Medtronic
- 5.1.4. Sorin Group
- 5.1.5. St. Jude Medical
- 5.1.6. CardioNet
- 5.1.7. LifeWatch
- 5.1.8. Corventis
- 5.1.9. Curvus
- 5.1.10. Q & S
- 5.1.11. SHL Telemedicine
- 5.1.12. Vitaphone
- 5.1.13. Zenicor
- 5.2. Blood pressure monitoring
- 5.2.1. Omron Healthcare
- 5.2.2. A&D Medical
- 5.2.3. Microlife
- 5.2.4. Rossmax
- 5.2.5. IEM
- 5.2.6. Medisana
- 5.3. Coagulation monitoring
- 5.3.1. Alere
- 5.3.2. CoaguSense
- 5.3.3. International Technidyne Corporation
- 5.4. Sleep monitoring
- 5.4.1. Fisher & Paykel Healthcare
- 5.4.2. Philips Respironics
- 5.4.3. ResMed
- 5.4.4. Cadwell Laboratories
- 5.4.5. CareFusion
- 5.4.6. Compumedics
- 5.4.7. Natus Medical
- 5.4.8. NovaSom
- 5.4.9. Watermark Medical
- 5.5. Blood oxygen monitoring
- 5.5.1. Covidien
- 5.5.2. Masimo
- 5.5.3. Nonin Medical
- 5.5.4. Opto Circuits
- 5.6. Air flow monitoring
- 5.6.1. Smiths Medical
- 5.6.2. Clement Clarke International
- 5.6.3. Medical Electronic Construction
- 5.6.4. Medical International Research
- 5.6.5. Midmark
- 5.6.6. Ndd Medizintechnik
- 5.6.7. nSpire Health
- 5.6.8. SDI Diagnostics
- 5.6.9. Sibelmed
- 5.6.10. Vitalograph
- 5.6.11. Welch Allyn
- 5.7. Glucose level monitoring
- 5.7.1. Abbott Laboratories
- 5.7.2. Bayer Healthcare
- 5.7.3. Johnson & Johnson
- 5.7.4. Roche
- 5.7.5. DexCom
- 5.7.6. Telcare
- 5.7.7. Welldoc
- 5.8. Lipid monitoring
- 5.8.1. CardioChek
- 5.8.2. Apex Biotechnology
- 5.8.3. Biomedix USA
6. Medication and integrated monitoring solution providers
- 6.1. Integrated telehealth solution providers
- 6.1.1. Bosch Healthcare
- 6.1.2. Honeywell HomMed
- 6.1.3. Cardiocom
- 6.1.4. Philips Healthcare
- 6.1.5. Numera
- 6.1.6. Viterion TeleHealthcare
- 6.1.7. Aerotel Medical Systems
- 6.1.8. American TeleCare
- 6.1.9. Authentidate
- 6.1.10. BlueLibris
- 6.1.11. BodyTel
- 6.1.12. Grandcare Systems
- 6.1.13. H2AD
- 6.1.14. Ideal Life
- 6.1.15. Intel-GE Care Innovations
- 6.1.16. MedApps
- 6.1.17. Medic4All
- 6.1.18. OBS Medical
- 6.1.19. Tunstall Group
- 6.1.20. Telehealth Solutions
- 6.2. Medication compliance monitoring
- 6.2.1. Aardex Group
- 6.2.2. Bang & Olufsen Medicom
- 6.2.3. Cypak
- 6.2.4. Information Mediary Corporation
- 6.2.5. Medicpen
- 6.2.6. Medsignals
- 6.2.7. Proteus Biomedical
- 6.2.8. SIMpill
- 6.2.9. Vitality
- 6.2.10. Vocel
7. Market analysis and forecasts
- 7.1. Market analysis
- 7.1.1. Cardiac implants comprise the bulk of RPM connections
- 7.1.2. Compliance requirements drive connectivity in the sleep therapy
market
- 7.1.3. Lower reimbursement slows down uptake of mobile cardiac telemetry
- 7.1.4. New entrants challenge leading providers of integrated telehealth
solutions
- 7.1.5. Wireless connectivity gains momentum in several market segments
- 7.1.6. Remote data transmission in other market segments
- 7.2. Market forecasts
- 7.3. Market drivers and barriers
- 7.3.1. An ageing population
- 7.3.2. Increasing welfare disease prevalence
- 7.3.3. Focus on disease prevention
- 7.3.4. Substitutes to medical monitoring
- 7.3.5. Resistance to change
- 7.4. Potential market catalysts
- 7.4.1. Increased monitoring during clinical trials
- 7.4.2. Insurance companies demanding monitoring
- 7.4.3. New clinical evidence on cost effectiveness
- 7.4.4. Non-prescribed monitoring and healthcare consumerism
- 7.5. Recommendations for mobile industry players
Glossary
List of Figures
- Figure 1.1: Population by age group (EU, North America and Japan 2010-2030)
- Figure 1.2: Direct and indirect costs of chronic welfare diseases in the
US and EU
- Figure 1.3: Number of people suffering from chronic welfare diseases
(EU/US 2008)
- Figure 1.4: Percentage of population diagnosed with chronic welfare
diseases
- Figure 1.5: Total and per capita healthcare spending by country (2009)
- Figure 1.6: Share of population covered by private health insurance by
country
- Figure 1.7: Healthcare expenditure per capita by country (US$, World 2007)
- Figure 1.8: Healthcare spending by type of service and product (US 2009)
- Figure 2.1: Overview of telecom eHealth and mHealth services
- Figure 2.2: mHealth market segments
- Figure 2.3: mHealth business models
- Figure 2.4: Mobile operators by number of subscribers (North America
Q4-2010)
- Figure 2.5: Mobile operators by number of subscribers (EU27+2 Q4-2010)
- Figure 2.6: Mobile operators by number of subscribers (APAC Q4-2010)
- Figure 3.1: Cost versus time diagram for wireless technology integration
- Figure 3.2: Examples of wireless M2M modules
- Figure 3.3: Examples of wireless M2M terminals
- Figure 3.4: System architecture for an end-to-end M2M solution
- Figure 3.5: M2M device value chain overview
- Figure 3.6: Leading smartphone vendors and operating systems (Q3-2011)
- Figure 3.7: Leading mobile app stores (Q3-2011)
- Figure 3.8: Examples of HealthVault-certified devices
- Figure 3.9: Examples of Continua-certified devices
- Figure 3.10: Selected members of the Continua Health Alliance, by industry
- Figure 4.1: Examples of methods for uploading health monitoring data
- Figure 4.2: Overview of remote ECG monitoring
- Figure 4.3: Heart sensor and monitor from CardioNet
- Figure 4.4: Blood pressure monitor from Omron Healthcare
- Figure 4.5: Glucose meters from LifeScan and Roche
- Figure 5.1: Major suppliers of physiological monitoring solutions (2010)
- Figure 5.2: Examples of home sleep therapy and diagnostics companies and
products
- Figure 5.3: Brands used by major diabetes monitoring companies
- Figure 6.1: Telehealth gateway form factors
- Figure 6.2: Examples of integrated monitoring solution providers
- Figure 6.3: The Honeywell Genesis DM telehealth monitor with peripherals
- Figure 6.4: The Vitality GlowCaps system
- Figure 7.1: Home medical monitoring market value by segment (World 2010 -
2016)
- Figure 7.2: Implantable cardiac rhythm management vendor market shares
(2010)
- Figure 7.3: Market shares for remote monitoring of cardiac implants (2011)
- Figure 7.4: Integrated telehealth solution provider market shares (2011)
- Figure 7.5: Installed base of telehealth hubs by region (2011)
- Figure 7.6: Home medical monitoring connections (World 2010 - 2016)
- Figure 7.7: Home medical monitoring connections by segment (World 2011)
- Figure 7.8: RPM connections by major market segments (World 2010 - 2016)
